Artificial intelligence to identify genetic alterations in conventional histopathology.

Abstract excerpt

Precision oncology relies on the identification of targetable molecular alterations in tumor tissues. In many tumor types, a limited set of molecular tests is currently part of standard diagnostic workflows. However, universal testing for all targetable alterations, especially rare ones, is limited by the cost and availability of molecular assays. From 2017 to 2021, multiple studies have shown that artificial...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Artificial Intelligence
• Share to High-Throughput Nucleotide Sequencing